3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Children's Health - Allergies - Asthma -

Asthma ‘drops’ may treat allergic asthma in kids

Children's Health • • Allergies • • AsthmaApr 03, 08

Children who suffer from asthma triggered by allergens - so-called allergic asthma—may benefit from an “under the tongue” therapy designed to increase tolerance to offending allergens, and, in turn, decrease asthma symptoms and medication use.

Research shows that sublingual immunotherapy, or SLIT, reduces symptoms and use of rescue medication use in children with allergic asthma, according to a report in the medical journal Chest. SLIT involves the oral administration of allergen extracts, either through soluble tablets or drops.

Dr. Giorgio Walter Canonica, of the University of Genoa, Italy, and colleagues pooled data from nine randomized, controlled clinical trials in order to assess the efficacy of SLIT in the treatment of allergic asthma in children.

A total of 441 children between the ages of 3 and 18 years were included in the analysis; 232 received SLIT and 209 received inactive placebo.

Treatment with SLIT resulted in a significant reduction in both symptoms of allergic asthma and medication use, Canonica and colleagues report.

The majority of side effects associated with SLIT were mild and self-resolving. The most common side effects were mouth symptoms, nose and eye symptoms, and stomach symptoms. No lethal or severe systemic reactions were reported.

Based on the evidence, Canonica and colleagues say SLIT is clinically effective in children with allergic asthma. However, additional research is needed to determine the most effective dose and regimen of administration.

“Also, clinical trials in children younger than 3 years of age should be designed and conducted to fully appreciate the possible preventive effect.”

SOURCE: Chest, March 2008.

Print Version
comments powered by Disqus

  Cell-associated HIV mucosal transmission: The neglected pathway
  UTSW researchers identify a therapeutic strategy that may treat a childhood neurological disorder
  Siblings of children with autism can show signs at 18 months
  Study finds hazardous flame retardants in preschools
  Study ties breathing problems, asthma to bone loss
  ADHD drugs not linked to increased stroke risk among children
  Online alcohol marketing easily accessed by kids
  Brain chemical ratios help predict developmental delays in preterm infants
  Common genetic pathway could be conduit to pediatric tumor treatment
  Think twice before buying breast milk online: study
  Child Abuse Ad Shows Hidden Message for Children
  90 percent of pediatric specialists not following clinical guidelines when treating preschoolers with ADHD


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site